Oral solids · Contract manufacturing in India

Selenium Dioxide 100 mcg, Vitamin A 5000 IU, Vitamin C 150 mg, Vitamin E 25 IU, Zinc Sulphate 10 mg Hard-gelatin capsules

Request manufacturing feasibility

Discuss third-party manufacturing of Selenium Dioxide 100 mcg, Vitamin A 5000 IU, Vitamin C 150 mg, Vitamin E 25 IU, Zinc Sulphate 10 mg Hard-gelatin capsules with Walter Healthcare, India. Share your target market, required capsule count and finished-pack count, packaging and launch timeline for a product-specific quotation.

Catalogue reference
WH-2360
Composition and strength
Selenium Dioxide 100 mcg, Vitamin A 5000 IU, Vitamin C 150 mg, Vitamin E 25 IU, Zinc Sulphate 10 mg
Dosage form
Hard-gelatin capsules
Indicative administration route
Oral
Therapeutic navigation area
Nutrition & supportive care
Pharmacological class
Nutritional supplement
Manufacturing stream
Non-beta-lactam

Catalogue details support an initial B2B discussion. Walter confirms the applicable unit, current licence scope, formula, target market and commercial feasibility before making a commitment.

Clinical reference

Mechanism and pharmacokinetics.

Explore the published evidence for the ingredients in Selenium Dioxide 100 mcg, Vitamin A 5000 IU, Vitamin C 150 mg, Vitamin E 25 IU, Zinc Sulphate 10 mg Hard-gelatin capsules. Each reference identifies its source formulation and study context. Ingredient studies describe the named reference product; they do not establish the pharmacokinetics, clinical suitability or bioequivalence of this finished formulation.

How to read our product information and sources ↗

Nutrient reference

Zinc

Reference for: Zinc Sulphate. Source presentation: oral nutrient reference. Source route: oral.

Biological role

Zinc participates in the catalytic activity of numerous enzymes and contributes to protein and DNA synthesis, cell signaling, cell division and normal immune function.

Absorption and disposition

Zinc balance depends on intestinal absorption, secretion into the gastrointestinal tract and reabsorption. Fractional absorption falls as intake rises. Much of the body zinc pool is in muscle and bone. This nutrient-level reference does not establish the absorption rate or bioavailability of a particular zinc salt or combination.

Nutrient-level summary from NIH. Absorption and disposition describe general oral nutritional physiology, not a pharmacokinetic or bioequivalence study of this finished product.

Source: NIH Office of Dietary Supplements: Zinc

Reference accessed .

Nutrient reference

Selenium

Reference for: Selenium Dioxide. Source presentation: oral nutrient reference. Source route: oral.

Biological role

Selenium is incorporated into selenoproteins including glutathione peroxidases and thioredoxin reductases. These proteins contribute to thyroid-hormone metabolism and protection against oxidative damage.

Absorption and disposition

Absorbed organic and inorganic selenium is metabolized toward an intermediate used to synthesize selenocysteine. A substantial body pool is in skeletal muscle. Urinary excretion is the main mechanism maintaining balance; excretion through feces and lungs also increases at high intake. This general physiology does not establish equal bioavailability among selenium compounds.

Nutrient-level summary from NIH. Absorption and disposition describe general oral nutritional physiology, not a pharmacokinetic or bioequivalence study of this finished product.

Source: NIH Office of Dietary Supplements: Selenium

Reference accessed .

Nutrient reference

Vitamin C

Reference for: Vitamin C. Source presentation: oral nutrient reference. Source route: oral.

Biological role

Ascorbic acid supports collagen, carnitine and neurotransmitter biosynthesis and acts as a physiological antioxidant. It also improves absorption of nonheme iron. These biological functions do not establish a disease-treatment benefit for an individual formulation.

Absorption and disposition

Oral absorption is dose-dependent: the NIH review reports about 70–90% at intakes of 30–180 mg/day and less than 50% above 1 g/day. Plasma and tissue concentrations are tightly regulated, and absorbed unmetabolized ascorbic acid is eliminated in urine. Oral data cannot be used as intravenous vitamin C pharmacokinetics.

Nutrient-level summary from NIH. Absorption and disposition describe general oral nutritional physiology, not a pharmacokinetic or bioequivalence study of this finished product.

Source: NIH Office of Dietary Supplements: Vitamin C

Reference accessed .

Nutrient reference

Vitamin E

Reference for: Vitamin E. Source presentation: oral nutrient reference. Source route: oral.

Biological role

Vitamin E encompasses fat-soluble compounds with antioxidant activity. Alpha-tocopherol is the form recognized as meeting human requirements; biological activity differs among tocopherols and tocotrienols.

Absorption and disposition

Vitamin E forms are absorbed in the small intestine and taken up by the liver. Hepatic alpha-tocopherol transfer protein preferentially returns alpha-tocopherol to the circulation, while the liver metabolizes and excretes other forms. This selective handling means different vitamin E forms should not be assigned identical pharmacokinetic values.

Nutrient-level summary from NIH. Absorption and disposition describe general oral nutritional physiology, not a pharmacokinetic or bioequivalence study of this finished product.

Source: NIH Office of Dietary Supplements: Vitamin E

Reference accessed .

Nutrient reference

Vitamin A

Reference for: Vitamin A. Source presentation: oral nutrient reference. Source route: oral.

Biological role

Vitamin A supports cell differentiation and normal epithelial tissues and is required for visual signaling through rhodopsin. Preformed retinoids and provitamin A carotenoids are different nutritional sources of vitamin A activity.

Absorption and disposition

Vitamin A forms enter intestinal micelles and are absorbed by duodenal cells. Retinyl esters and provitamin A carotenoids undergo conversion to retinol at different stages of uptake. The NIH review reports variable absorption across forms; these nutrient findings should not be treated as equivalent bioavailability for retinol, beta-carotene and retinoid medicines.

Nutrient-level summary from NIH. Absorption and disposition describe general oral nutritional physiology, not a pharmacokinetic or bioequivalence study of this finished product.

Source: NIH Office of Dietary Supplements: Vitamin A

Reference accessed .

Manufacturing & packaging brief

Plan the hard-capsule presentation.

Use this preparation guide for Selenium Dioxide 100 mcg, Vitamin A 5000 IU, Vitamin C 150 mg, Vitamin E 25 IU, Zinc Sulphate 10 mg Hard-gelatin capsules. These are the decisions to resolve with the technical team before a site, process and commercial scope are confirmed.

Presentation & formulation

Confirm the fill type, shell material, capsule size and printing requirements. Distinguish powder, granule and pellet fills where relevant to the proposed formulation.

Quality & technical transfer

Request review of the fill specification, shell compatibility, analytical methods and applicable release testing. Identify any established formula or transfer package.

Review the technical documents

Packaging configuration

Specify capsules per blister or bottle, the proposed barrier material and carton configuration. Include shell and print requirements in the quotation scope.

Explore packaging options

Details to confirm for this record

Full composition
Keep all named components and their individual amounts together in the specification. Ingredient substitutions, omissions and changed ratios require a separate formula and permission review.
Salt and strength wording
Confirm whether the stated amount refers to the named salt, hydrate or equivalent active moiety. Use the agreed expression consistently in the specification, quotation and artwork.
Concentration and pack size
The record does not state a complete concentration basis. Confirm the amount per volume or weight before a specification, label or quotation is finalised; no denominator has been assumed here.

Quantities, MOQ & lead time

For Selenium Dioxide 100 mcg, Vitamin A 5000 IU, Vitamin C 150 mg, Vitamin E 25 IU, Zinc Sulphate 10 mg Hard-gelatin capsules (WH-2360), state the capsule count and finished-pack count, target market and reorder forecast. MOQ and lead time depend on the assessed formula, process, components, testing and project readiness; request those terms in writing.

Discuss this manufacturing brief

Explore the context

Build the right manufacturing brief.

Common questions

Before you request a quotation.

Selenium Dioxide 100 mcg, Vitamin A 5000 IU, Vitamin C 150 mg, Vitamin E 25 IU, Zinc Sulphate 10 mg Hard-gelatin capsules

What is listed in the catalogue?

The catalogue lists Selenium Dioxide 100 mcg, Vitamin A 5000 IU, Vitamin C 150 mg, Vitamin E 25 IU, Zinc Sulphate 10 mg as hard-gelatin capsules in its nutrition & supportive care navigation area and non-beta-lactam manufacturing stream.

How do you confirm manufacturing availability?

Send Walter your requirement for Selenium Dioxide 100 mcg, Vitamin A 5000 IU, Vitamin C 150 mg, Vitamin E 25 IU, Zinc Sulphate 10 mg Hard-gelatin capsules. The team reviews the applicable product permission and unit, formulation and equipment fit, testing, packaging and production schedule before confirming the manufacturing scope in writing. Request the relevant product and facility documents with your enquiry.

What do I need for a quotation?

Share the exact composition and strength, hard-gelatin capsules presentation, target market, initial quantity, preferred pack and timing. Identify whether this is a new product, development brief or transfer.

The quotation must confirm MOQ, inclusions, prerequisites and lead time for the proposed product and site.

What is needed for Indian and export markets?

For India, share the intended brand or institutional supply requirement, pack sizes, initial order quantity and artwork needs for Selenium Dioxide 100 mcg, Vitamin A 5000 IU, Vitamin C 150 mg, Vitamin E 25 IU, Zinc Sulphate 10 mg Hard-gelatin capsules. Confirm the applicable product permission, manufacturing unit and labelling requirements with the team.

For export, identify each destination country, proposed pack, language and registration or dossier requirements. Ask which product-specific quality and stability documents are available. Container compatibility and destination-market requirements need review; a catalogue record does not establish export registration or a shelf-life commitment.

How do I submit my enquiry?

Use the product-specific enquiry button to carry this composition and dosage form into the form. After a successful submission, a receipt reference confirms that your brief has been saved for review. Use the RFQ checklist to prepare the remaining details.

Technical document review

Which documents can I ask Walter to review?

Ask about manufacturing and packing records, specifications, analytical methods, Certificates of Analysis (COA), stability evidence, the Process Validation Protocol (PVP) and Process Validation Report (PVR). The wider checklist below covers supplier qualification, technical transfer and ongoing supply.

View the full document checklist 14 review areas
Site, licence and audit scope
Manufacturing licence, applicable product permissions, GMP certificates, Site Master File, supplier-qualification questionnaire and relevant audit responses.
Manufacturing, packing and batch release
Master Formula Record (MFR), master packing instructions, Batch Manufacturing Record (BMR), Batch Packing Record (BPR), reconciliation and authorised release records.
Process validation and continued verification
Process Validation Protocol (PVP), Process Validation Report (PVR), process performance qualification documents and continued process verification trends.
Equipment, facilities and utilities
Validation Master Plan (VMP), user requirements, DQ/IQ/OQ/PQ records, calibration and maintenance evidence for relevant equipment and utilities.
Cleaning, carryover and hold times
Cleaning Validation Protocol (CVP), Cleaning Validation Report (CVR), residue limits, recovery studies and applicable clean, dirty and process hold-time studies.
Specifications and analytical evidence
Specifications, Method of Analysis (MOA), Standard Testing Procedure (STP), Certificates of Analysis (COA), analytical validation, verification and method-transfer records.
Stability, packaging and transport
Stability protocols/reports, ongoing stability commitments, pack specifications, approved artwork, compatibility and applicable packaging or transport studies.
Development and technology transfer
Development report, technology-transfer protocol/report, gap assessment, control strategy, critical quality attributes and critical process parameters.
Quality reviews, investigations and changes
Product Quality Review (PQR) / Annual Product Review (APR), deviations, CAPA, change control, OOS/OOT trends, complaints, recalls and relevant SOP/training records.
Material suppliers and impurity risks
API/excipient supplier qualification, traceability, material COAs, relevant origin declarations and impurity risk assessments with supporting tests.
Sterile-product evidence, where applicable
Contamination Control Strategy (CCS), media-fill/aseptic simulation reports, sterilisation and filtration validation, environmental monitoring, sterility/endotoxin and container-closure integrity evidence.
Computerised systems and data integrity
Computerised-system validation, access controls, audit-trail review, backup/restore checks and relevant data-integrity procedures.
Market-specific regulatory support
Applicable dossier sections, API master-file/CEP support, bioequivalence or biowaiver evidence and Certificate of a Pharmaceutical Product (CPP/CoPP), where required and available.
Quality agreement and access arrangements
Quality/technical agreement covering responsibilities, release, changes, subcontracting, investigations, complaints, recalls, audits and document access.

Agree the list for the exact product, site, process, pack, market and project stage. QA confirms what exists, applies and may be shared; some records may require an NDA, redaction or controlled review. See document definitions and review guidance.

Important qualification

This B2B catalogue record is not proof of current approval or confirmation that Selenium Dioxide 100 mcg, Vitamin A 5000 IU, Vitamin C 150 mg, Vitamin E 25 IU, Zinc Sulphate 10 mg Hard-gelatin capsules is available for sale. It is not prescribing information or patient advice. Any Drugs Rules status, current approval, exemption, applicable unit, licence scope, formulation, claims, brand use, destination-market registration and commercial feasibility require documentary verification and Walter's written confirmation. Read the full regulatory disclaimer.

Composition and classification are taken from Walter's product catalogue. The manufacturing guide helps buyers prepare a technical brief. Clinical references, where shown, describe the cited product and study. Manufacturing guide updated .